Fingerprint
Dive into the research topics of 'A randomized phase 2 study exploring the role of bevacizumab and a chemotherapy-free approach in HER2-positive metastatic breast cancer: The HAT study (BOOG 2008-2003), a Dutch Breast Cancer Research Group trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically